TREAT: Translational Research in Alcohol Treatment

Transforming treatments for alcohol use disorder
with precision medicine. NHMRC Synergy, 2022.

[Turning Point @TurningPointAU]

🚀Applications Now Open: Fully-Funded PhD Opportunity at the Forefront of Neuroscience-Informed Addiction Treatment

Find out more here: https://t.co/IE5Z8iq4Cy

[Turning Point @TurningPointAU]

Professor @Dan_Lubman recently had the opportunity to join @TheFlorey's podcast, The Brain Matters, to explore addiction - what it is, how it develops and how neuroscience can inform treatment.

Listen wherever you get your podcasts, or on Spotify: https://t.co/ntcylHLCGi

[Journals of The American Psychiatric Association @APAPubJournals]

A study comparing topiramate with naltrexone found topiramate to be at least as effective and safe as the first-line medication naltrexone in reducing heavy alcohol consumption and superior in reducing some clinical outcomes. @DrKirstenMorley https://t.co/xAQXiX26XY

[The Florey @TheFlorey]

What does science say about alcohol addiction?

Prof Andrew Lawrence, Head of our Addiction Neuroscience Group, spoke with @theheraldsun about the importance of destigmatising addiction and defining it as a medical condition.

Read here: https://t.co/aXUSSAwaXD

#TheFlorey

[Monash Addiction Research Centre @MonashAddiction]

A group of experts in addiction from @MonashAddiction is presenting this week at the 2024 World Congress on Alcohol & Addictions in Melbourne. @ISBRAComm

Looking forward to hearing about the discussions with the world's leading experts in this field.

+ https://t.co/Ft2aXLJ4Px

[The Florey @TheFlorey]

📸 Today, our Addiction Neuroscience Group is attending the 2024 World Congress on Alcohol and Addictions at Melbourne Convention and Exhibition Centre.

We're ready for some great discussions with the world's experts in this space: https://t.co/ZygZNdfD9n

@ISBRAComm #TheFlorey

[Turning Point @TurningPointAU]

Help us characterise individuals living with alcohol use disorder in the community. If you meet the following criteria, we would like to hear from you!

- Alcohol consumption exceeds the Aus guidelines
- 18 + years
- Living in Australia

Click here: https://t.co/jFT5tczgNm

[Turning Point @TurningPointAU]

When Gene* was offered the chance to participate in a trial investigating a promising new antioxidant that could help people reduce their alcohol intake, he was keen to sign up.

Read about Gene’s experiences, including the medical support he received: https://t.co/4EnnlOsPve

[Prof Kirsten Morley @DrKirstenMorley]

Head to head genotype-stratified trial of topiramate vs naltrexone!
Topiramate was as effective and safe as naltrexone, but superior on some outcomes. There were no sig effects of rs2832407 nor rs1799971 @AlcoholSynergy @SydneyResearch @syd_health https://t.co/5QguViKN5v

[TREAT: Translational Research in Alcohol Treatment @AlcoholSynergy]

Find out more about the @AlcoholSynergy team’s work investigating new pharmacological targets
https://t.co/QwxodXEske

[TREAT: Translational Research in Alcohol Treatment @AlcoholSynergy]

Can a drug like Ozempic help treat addictions to alcohol, opioids or other substances?

@AlcoholSynergy experts @SArunogiri @LeighWalkerPhD & Roberta Goncalves explore their rise, impact and potential consequences in @ConversationEDU

https://t.co/GyiVsCOHUV

[Prof Kirsten Morley @DrKirstenMorley]

Come work with us! Interested in addiction treatment research? Keen on clinical trials, neuroscience, neuropharmacology and/or neuropsychology? Join our NHMRC Synergy research program! @Edith__Collins @gavanm @dan_lubman @SArunogiri @drvictoriamann1 https://t.co/Jyr9548FG6

[Shalini Arunogiri @SArunogiri]

Great opportunity for #postdoc position in #alcohol #neuroscience working with a fantastic interdisciplinary team

@SOBRNetwork @Postdocjobsaus @TheFlorey
@AlcoholSynergy